James Harris
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
Papers in
-
- Renal Transplantation Outcomes and Treatments 4
- Anatomy 2
- Co-authors
- Donald P. BraunGeoffrey FalksonD C TormeyE. M. HershEmil J. FreireichC. M. McBridePaul ElkingtonJon S. Friedland
- Journals
- Prostaglandins Leukotrienes and Essential Fatty Acids (4 papers)Journal of Clinical Oncology (4 papers)Journal of Medical Economics (4 papers)Cancer (2 papers)The Prostate (2 papers)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
James Harris
65 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 263
- Immunology 328
- Oncology 326
- Virology 36
- Biochemistry 52
Countries citing papers authored by James Harris
This map shows the geographic impact of James Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Harris more than expected).
Fields of papers citing papers by James Harris
This network shows the impact of papers produced by James Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Harris. The network helps show where James Harris may publish in the future.
Co-authors
The 25 scholars most cited alongside James Harris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 0 | |
| 8 | 2007 | 45 | |
| 9 | 2001 | 5 | |
| 10 | 1999 | 8 | |
| 11 | 1998 | 84 | |
| 12 | 1997 | 15 | |
| 13 | 1992 | 5 | |
| 14 | 1992 | 18 | |
| 15 | 1991 | 1 | |
| 16 | 1990 | 9 | |
| 17 | 1989 | 42 | |
| 18 | 1989 | 13 | |
| 19 | 1988 | 38 | |
| 20 | High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study. | 1987 | 21 |
About James Harris
James Harris is a scholar working on Transplantation, Anatomy, Nephrology, Biophysics and Biochemistry, having authored 71 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Breast Cancer Treatment Studies (6 papers), Chronic Kidney Disease and Diabetes (6 papers), Dialysis and Renal Disease Management (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Electron Spin Resonance Studies (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). The work is most often cited by research in Cancer Research (263 citations), Immunology (328 citations), Oncology (326 citations), Virology (36 citations) and Biochemistry (52 citations). James Harris has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Donald P. Braun, Geoffrey Falkson, D C Tormey, E. M. Hersh, Emil J. Freireich, C. M. McBride, Paul Elkington, Jon S. Friedland, Robert J. Gray and J. E. Curtis. Their work appears in journals such as Prostaglandins Leukotrienes and Essential Fatty Acids, Journal of Clinical Oncology, Journal of Medical Economics, Cancer and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.